Yüklüyor......
5PSQ-031 Pneumocystis carinii pneumonia prevention in lung transplantation: is atovaquone effective?
BACKGROUND: Pneumocystis carinii pneumonia (PCP) is an uncommon severe complication in immunocompromised patients. There is only one marketed treatment to prevent PCP: trimethoprime-sulfamethoxazole (TMP-SMZ). Due to side-effects (mainly neutropaenia), TMP-SMZ is sometimes replaced by off-label drug...
Kaydedildi:
| Yayımlandı: | Eur J Hosp Pharm |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMJ Group
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535716/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.385 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|